Name: Name:N-[2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]-methanesulfonamide
Brand: AABLOCKS
SKU: AA008XD2
Rating: 90 (10 reviews)

Catalog No.: AA008XD2

1083326-75-3 | N-[2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]-methanesulfonamide

Pack Size： 100mg

Purity： 95%

in stock

$85.00 $60.00

Pack Size： 250mg

Purity： 95%

in stock

$147.00 $103.00

Pack Size： 1g

Purity： 95%

in stock

$389.00 $272.00

Pack Size： 5g

Purity： 97%

in stock

$1,680.00 $1,176.00

Quantity

- +

Add to Card

Order Now

bulk Quotation Request

Technical Information

Catalog Number: AA008XD2

Chemical Name: N-[2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]-methanesulfonamide

CAS Number: 1083326-75-3

Molecular Formula: C13H21BN2O5S

Molecular Weight: 328.1922

MDL Number: MFCD12964555

SMILES: COc1ncc(cc1NS(=O)(=O)C)B1OC(C(O1)(C)C)(C)C

Properties

Complexity: 489

Covalently-Bonded Unit Count: 1

Defined Atom Stereocenter Count: 0

Defined Bond Stereocenter Count: 0

Formal Charge: 0

Heavy Atom Count: 22

Hydrogen Bond Acceptor Count: 7

Hydrogen Bond Donor Count: 1

Isotope Atom Count: 0

Rotatable Bond Count: 4

Undefined Atom Stereocenter Count: 0

Undefined Bond Stereocenter Count: 0

Upstream Synthesis Route

1083327-58-5

73183-34-3

1083326-75-3

[1]OrganicProcessResearchandDevelopment,2018,vol.22,#3,p.368-376

[2]Patent:US2014/134133,2014,A1,.Locationinpatent:Paragraph0441

[3]BioorganicandMedicinalChemistry,2018,vol.26,#3,p.637-646

[4]JournalofMedicinalChemistry,2018,vol.61,#14,p.6087-6109

[5]EuropeanJournalofMedicinalChemistry,2018,vol.146,p.460-470

[6]BioorganicandMedicinalChemistry,2018,vol.26,#8,p.1675-1685

[7]Patent:WO2012/32067,2012,A1,.Locationinpatent:Page/Pagecolumn61

[8]Patent:WO2014/28968,2014,A1,.Locationinpatent:Page/Pagecolumn87;88

[9]Patent:US9326987,2016,B2,.Locationinpatent:Page/Pagecolumn166;167

[10]Patent:CN106674200,2017,A,.Locationinpatent:Paragraph0096;0097

893440-50-1

124-63-0

1083326-75-3

[1]JournalofMedicinalChemistry,2015,vol.58,#18,p.7381-7399

[2]Patent:WO2010/102958,2010,A1,.Locationinpatent:Page/Pagecolumn98;99

[3]Patent:WO2011/67365,2011,A1,.Locationinpatent:Page/Pagecolumn69

[4]Patent:WO2012/32067,2012,A1,.Locationinpatent:Page/Pagecolumn55

[5]Patent:WO2014/60432,2014,A1,.Locationinpatent:Page/Pagecolumn130

[6]Patent:US9326987,2016,B2,.Locationinpatent:Page/Pagecolumn95;133

[7]Patent:WO2009/147187,2009,A1,.Locationinpatent:Page/Pagecolumn114

[8]Patent:WO2010/125082,2010,A1,.Locationinpatent:Page/Pagecolumn75

884495-39-0

1083326-75-3

[1]Patent:WO2011/67365,2011,A1,

[2]Patent:WO2012/32067,2012,A1,

[3]Patent:WO2012/32067,2012,A1,

[4]Patent:WO2014/28968,2014,A1,

[5]Patent:US2014/134133,2014,A1,

[6]Patent:US9326987,2016,B2,

[7]Patent:US9326987,2016,B2,

[8]BioorganicandMedicinalChemistry,2018,vol.26,#3,p.637-646

[9]EuropeanJournalofMedicinalChemistry,2018,vol.146,p.460-470

[10]BioorganicandMedicinalChemistry,2018,vol.26,#8,p.1675-1685

[11]JournalofMedicinalChemistry,2018,vol.61,#14,p.6087-6109

[12]Patent:WO2009/147187,2009,A1,

[13]Patent:WO2010/125082,2010,A1,

893440-50-1

124-63-0

1083326-75-3

[1]Patent:WO2014/60431,2014,A1,.Locationinpatent:Page/Pagecolumn85-86

73183-34-3

1083326-75-3

[1]Patent:WO2011/67365,2011,A1,

[2]Patent:WO2012/32067,2012,A1,

[3]Patent:WO2014/60431,2014,A1,

[4]Patent:US9326987,2016,B2,

[5]Patent:WO2009/147187,2009,A1,

[6]Patent:WO2010/125082,2010,A1,

Downstream Synthesis Route

893440-50-1

124-63-0

1083326-75-3

[1]JournalofMedicinalChemistry,2015,vol.58,p.7381-7399

[2]Patent:WO2010/102958,2010,A1.Locationinpatent:Page/Pagecolumn98;99

[3]Patent:WO2011/67365,2011,A1.Locationinpatent:Page/Pagecolumn69

[4]Patent:WO2012/32067,2012,A1.Locationinpatent:Page/Pagecolumn55

[5]Patent:WO2014/60432,2014,A1.Locationinpatent:Page/Pagecolumn130

[6]Patent:US9326987,2016,B2.Locationinpatent:Page/Pagecolumn95;133

[7]Patent:WO2009/147187,2009,A1.Locationinpatent:Page/Pagecolumn114

[8]Patent:WO2010/125082,2010,A1.Locationinpatent:Page/Pagecolumn75

1083326-75-3

1245465-34-2

1245466-41-4

[1]Patent:WO2010/102958,2010,A1.Locationinpatent:Page/Pagecolumn148;149

[2]Patent:US9326987,2016,B2.Locationinpatent:Page/Pagecolumn192;193

1083326-75-3

1245465-37-5

1245466-45-8

[1]Patent:WO2010/102958,2010,A1.Locationinpatent:Page/Pagecolumn156;157;158

[2]Patent:US9326987,2016,B2.Locationinpatent:Page/Pagecolumn199;200

1083326-75-3

1245465-38-6

1245465-47-7

[1]Patent:WO2010/102958,2010,A1.Locationinpatent:Page/Pagecolumn115;116

[2]Patent:US9326987,2016,B2.Locationinpatent:Page/Pagecolumn112;113

1083326-75-3

1245465-40-0

1245465-88-6

[1]Patent:WO2010/102958,2010,A1.Locationinpatent:Page/Pagecolumn151;152

[2]Patent:US9326987,2016,B2.Locationinpatent:Page/Pagecolumn194;195

Building Blocks More >

1082041-59-5

5-Iodo-6-methoxy-1h-indazole

AA008XNO | MFCD11007886

1080-89-3

5-Methyl-2-phenyl-2h-pyrazole-3,4-dione 4-oxime

AA008Y28 | MFCD00448519

106881-77-0

(E)-1-(Pyridin-3-yl)ethanone oxime

AA008YOT | MFCD00179685

1187931-26-5

(1S)-1-(2-Bromophenyl)ethan-1-amine hydrochloride

AA008Z21 | MFCD09997783

109213-85-6

(3-METHACRYLAMIDOPROPYL)TRIETHOXYSILANE, tech-95

AA008ZJV | MFCD00156464

1050424-03-7

4-Borono-2-(trifluoromethyl)benzoic acid

AA0090C3 | MFCD11856032

1184986-84-2

(5-Methyl-1,2,4-oxadiazol-3-yl)methanamine hydrochloride

AA0090IM | MFCD11506367

1135282-81-3

1-(2-((2-(Trifluoromethyl)phenyl)amino)thiazol-5-yl)ethanone

AA0090UO | MFCD11840951

106873-99-8

N-Formyl-dl-2-amino-n-butyric acid

AA0090YD | MFCD00059813

1173021-81-2

Ammelide -13C3

AA0091SR | MFCD12546074